Biotech

All Articles

Kairos goes public along with $6M IPO to fund tests of cancer medication

.Along with a triad of biotechs attacking the Nasdaq on Friday, it was actually very easy to miss a ...

Vaccine and Keytruda combination efficient in squamous tissue carcinoma

.Invulnerable checkpoint preventions are the superheroes of cancer cells treatment. Medications like...

Cue Biopharma mark time J&ampJ vet as CBO-- Chutes &amp Ladders

.Accept to recently's Chutes &amp Ladders, our summary of considerable leadership hirings, shootings...

Regeneron's Opdualag opponent presents 57% feedback fee

.Regeneron is actually back with long-term consequence for its LAG-3 prevention as well as PD-1 prev...

AstraZeneca articles information on internal rivals to AbbVie, Pfizer ADCs

.AstraZeneca has actually shared an early examine the performance of its own in-house antibody-drug ...

iTeos- GSK's TIGIT star shows relevant enhancement

.After introducing a period 3 launch based upon positive midstage outcomes, iTeos and also GSK are a...

More collaborative FDA can accelerate rare ailment R&ampD: file

.The FDA must be actually a lot more open as well as collaborative to unleash a surge in approvals o...

Zenas, MBX, Bicara head to Nasdaq in warm time for biotech IPOs

.It is actually an unusually occupied Friday for biotech IPOs, along with Zenas BioPharma, MBX and a...

Atea's COVID antiviral stops working to stop hospital stays in phase 3

.Atea Pharmaceuticals' antiviral has neglected another COVID-19 test, yet the biotech still keeps ou...

Neurocrine's quote to conserve mental illness possibility neglects

.Neurocrine Biosciences' schizophrenia program pivot has actually fallen short. The biotech was actu...